Table 1.
Baseline characteristics of participants and design characteristics of included articles.
| Literature | Year | Study Region | Mean Age (Years) | Number of Participants (M/C) | MUFA Source | Amount of MUFA (M/C) | Study Design |
|---|---|---|---|---|---|---|---|
| Salar-1 [23] | 2016 | Iran (Asia) | 51.42 | 24/23 | Canola oil | 6.9/6.5 a | Parallel |
| Salar-2 [23] | 2016 | Iran (Asia) | 51.42 | 25/23 | Rice bran oil | 7.63/6.5 a | Parallel |
| Negele [24] | 2015 | Austria | 11.1 | 12/9 | Rapeseed oil | NA | Parallel |
| Welma-1 [26] | 2021 | Australia | 32.66 | 20/22 | Palm olein | 25.65/9.42 b | Parallel |
| Welma-2 [26] | 2021 | Australia | 32.66 | 20/21 | Palm olein | 25.65/15.14 b | Parallel |
| Wang-1 [28] | 2015 | America | 45 | 42/43 | Avocado | 17/12 a | Crossover |
| Wang-2 [28] | 2015 | America | 45 | 43/43 | High oleic acid oils | 17/12 a | Crossover |
| Pieterse [25] | 2005 | South Africa | 40.8 | 28/27 | Avocado | 20/0 b | Parallel |
| Griel [27] | 2008 | America | 50.2 | 25/25 | Nut | 18/12 a | Crossover |
| Mercanligil [22] | 2007 | Turkey (Asia) | 48.0 | 15/15 | Hazelnut | 17–20/13–15 a | Crossover |
M: MUFA-rich diet, C: control diet; a: the amount of daily MUFA intake (% of total energy); b: the amount of daily MUFA intake (g).